Upgrade to SI Premium - Free Trial

Cognex Announces Q4 2020 Results

February 11, 2021 4:06 PM

Cognex Reports Record Fourth Quarter and Full Year Revenue for 2020

NATICK, Mass.--(BUSINESS WIRE)-- Cognex Corporation (NASDAQ: CGNX) today reported financial results for 2020. Table 1 below shows selected financial data for Q4-20 compared with Q4-19 and Q3-20, and the year ended December 31, 2020 compared with the year ended December 31, 2019.

Table 1

(Dollars in thousands, except per share amounts)

Revenue

Net Income

Net Income
per Diluted
Share

Non-GAAP
Net Income
per Diluted
Share*

Quarterly Comparisons

Current quarter: Q4-20

$223,615

$69,345

$0.39

$0.32

Prior year’s quarter: Q4-19

$169,769

$80,327

$0.46

$0.11

Change: Q4-19 to Q4-20

32%

(14)%

(15)%

191%

Prior quarter: Q3-20

$251,073

$87,506

$0.49

$0.47

Change: Q3-20 to Q4-20

(11)%

(21)%

(20)%

(32)%

Yearly Comparisons

Year ended December 31, 2020

$811,020

$176,186

$1.00

$1.09

Year ended December 31, 2019

$725,625

$203,865

$1.16

$0.80

Change from 2019 to 2020

12%

(14)%

(14)%

36%

*Non-GAAP net income per diluted share excludes restructuring and other charges that occurred predominantly in Q2-20, and tax adjustments for all periods presented. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.

“It’s hard to call 2020 a ‘good’ year, but we are, nevertheless, pleased with the financial results that we were able to achieve,” said Dr. Robert J. Shillman, Founder and Chairman of Cognex. “We set a new record for both Q4 and annual revenue despite significant economic disruption and weakness in the automotive industry. Importantly, we remained focused on long-term growth opportunities, which we believe has positioned us well going into 2021.”

“The past year was a turbulent time for most businesses, including Cognex,” said Robert J. Willett, Chief Executive Officer of Cognex. “We are proud of our achievements, and the continued dedication and hard work of Cognoids around the world during this difficult period. While economic conditions remain unpredictable, we are cautiously optimistic that the strength we experienced in the second half of 2020 will continue into the new year.”

Summary of the Year

Cognex reported record revenue of $811 million in 2020—representing an increase of 12% year-on-year―despite significant disruptions to the global economy during the year. Revenue growth was due to higher revenue from consumer electronics and the e-commerce fulfillment sector of logistics, and particularly from large customers that benefited from higher consumer demand during the COVID-19 pandemic. Revenue from medical-related industries also increased, though considerably less than the increase from consumer electronics and logistics.

Operating income on a GAAP basis was 21% of revenue compared to 20% for 2019 because of the higher revenue. Cognex remained focused on the long term and invested a record $131 million, or 16% of revenue, in engineering, marking the company’s tenth consecutive year of Research, Development and Engineering (RD&E) growth. We believe that our position as a leader in machine vision is due, in large part, to the engineering content in our products, and we intend to continue to invest in RD&E going forward. The company recorded pre-tax restructuring charges of approximately $16 million for steps taken to reduce expenses, including a workforce reduction and lease terminations. In addition, Cognex recorded non-cash charges of approximately $27 million in the second quarter for the impairment of intangible assets and write-down of excess and obsolete inventory due to the deteriorated business conditions. Excluding restructuring and other charges, operating income was 27% of revenue for 2020 compared to 20% in the prior year.

Details of the Quarter

Statement of Operations Highlights – Fourth Quarter of 2020

Balance Sheet Highlights – December 31, 2020

Financial Outlook – Q1 2021

Non-GAAP Financial Measures

Analyst Conference Call and Simultaneous Webcast

About Cognex Corporation

Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.

Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.

Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on our assets, business and results of operations, customer order rates and timing of related revenue, future product mix, restructuring and other cost-savings initiatives, research and development activities, capital projects, investments, acquisitions, liquidity, dividends and stock repurchases, strategic plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products; (6) the failure to effectively manage product transitions or accurately forecast customer demand; (7) the inability to design and manufacture high-quality products; (8) the inability to attract and retain skilled employees and maintain our unique corporate culture; (9) the failure to effectively manage our growth; (10) the inability to achieve growth in revenue and profits from the logistics industry; (11) the technological obsolescence of current products and the inability to develop new products; (12) the failure to properly manage the distribution of products and services; (13) the impact of competitive pressures; (14) the challenges in integrating and achieving expected results from acquired businesses; (15) potential disruptions in our business systems; (16) information security breaches; (17) the inability to protect our proprietary technology and intellectual property; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) our involvement in time-consuming and costly litigation; (22) unfavorable global economic conditions; (23) economic, political, and other risks associated with international sales and operations; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2020. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.

Exhibit 1

COGNEX CORPORATION

Statements of Operations

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended

Twelve-months Ended

December 31,
2020

September 27,
2020

December 31,
2019

December 31,
2020

December 31,
2019

Revenue

$

223,615

$

251,073

$

169,769

$

811,020

$

725,625

Cost of revenue (1)

55,160

59,741

44,871

206,421

189,754

Gross margin

168,455

191,332

124,898

604,599

535,871

Percentage of revenue

75

%

76

%

74

%

75

%

74

%

Research, development, and engineering
expenses (1)

34,399

30,240

32,991

130,982

119,427

Percentage of revenue

15

%

12

%

19

%

16

%

16

%

Selling, general, and administrative expenses (1)

74,096

64,206

74,300

267,593

273,842

Percentage of revenue

33

%

26

%

44

%

33

%

38

%

Restructuring charges

875

251

15,924

Intangible asset impairment charges

19,571

Operating income

59,085

96,635

17,607

170,529

142,602

Percentage of revenue

26

%

38

%

10

%

21

%

20

%

Foreign currency gain (loss)

4,007

2,357

894

3,697

(509

)

Investment and other income

1,828

2,317

4,420

12,685

20,901

Income before income tax expense (benefit)

64,920

101,309

22,921

186,911

162,994

Income tax expense (benefit)

(4,425

)

13,803

(57,406

)

10,725

(40,871

)

Net income

$

69,345

$

87,506

$

80,327

$

176,186

$

203,865

Percentage of revenue

31

%

35

%

47

%

22

%

28

%

Net income per weighted-average common and common-equivalent share:

Basic

$

0.40

$

0.50

$

0.47

$

1.02

$

1.19

Diluted

$

0.39

$

0.49

$

0.46

$

1.00

$

1.16

Weighted-average common and common-equivalent shares outstanding:

Basic

175,220

173,943

171,607

173,489

171,194

Diluted

178,590

177,138

175,500

176,592

175,269

Cash dividends per common share

$

2.060

$

0.055

$

0.055

$

2.225

$

0.205

Cash and investments per common share

$

4.37

$

5.80

$

4.90

$

4.37

$

4.90

Book value per common share

$

7.18

$

8.62

$

7.86

$

7.18

$

7.86

(1) Amounts include stock-based compensation expense, as follows:

Cost of revenue

$

324

$

324

$

390

$

1,365

$

1,504

Research, development, and engineering

2,805

2,815

4,115

13,387

15,748

Selling, general, and administrative

7,456

6,129

7,642

27,909

28,337

Total stock-based compensation expense

$

10,585

$

9,268

$

12,147

$

42,661

$

45,589

Exhibit 2

COGNEX CORPORATION

Reconciliation of Selected Items from GAAP to Non-GAAP

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended

Twelve-months Ended

December 31,
2020

September 27,
2020

December 31,
2019

December 31,
2020

December 31,
2019

Discrete tax adjustments reconciliation

Income before income tax expense (benefit) (GAAP)

$

64,920

$

101,309

$

22,921

$

186,911

$

162,994

Income tax expense (benefit) (GAAP)

$

(4,425

)

$

13,803

$

(57,406

)

$

10,725

$

(40,871

)

Effective tax rate (GAAP)

(7

)

%

14

%

(250

)

%

6

%

(25

)

%

Discrete tax benefit related to stock-based compensation

2,342

4,354

1,925

12,788

6,472

Discrete tax benefit (expense) related to tax return filings and other

11,441

(129

)

602

7,803

1,932

Discrete tax expense related to migration of acquired IP

(28,528

)

(28,528

)

Discrete tax benefit related to change in tax structure

87,500

87,500

Total discrete tax adjustments

$

13,783

$

4,225

$

61,499

$

20,591

$

67,376

Income tax expense (benefit) (Non-GAAP)

$

9,358

$

18,028

$

4,093

$

31,316

$

26,505

Effective tax rate (Non-GAAP)

14

%

18

%

18

%

17

%

16

%

Exclusion of restructuring and other charges

Operating income (GAAP)

$

59,085

$

96,635

$

17,607

$

170,529

$

142,602

Percentage of revenue (GAAP)

26

%

38

%

10

%

21

%

20

%

Excess and obsolete inventory charges

522

603

1,175

9,908

5,296

Restructuring charges

875

251

15,924

Intangible asset impairment charges

19,571

Operating income (Non-GAAP)

$

60,482

$

97,489

$

18,782

$

215,932

$

147,898

Percentage of revenue (Non-GAAP)

27

%

39

%

11

%

27

%

20

%

Restructuring and other charges and discrete tax adjustments reconciliation

Net income (GAAP)

$

69,345

$

87,506

$

80,327

$

176,186

$

203,865

Excess and obsolete inventory charges

522

603

1,175

9,908

5,296

Restructuring charges

875

251

15,924

Intangible asset impairment charges

19,571

Tax effect on restructuring and other charges

(196

)

(154

)

(188

)

(7,719

)

(847

)

Discrete tax adjustments

(13,783

)

(4,225

)

(61,499

)

(20,591

)

(67,376

)

Net income (Non-GAAP)

$

56,763

$

83,981

$

19,815

$

193,279

$

140,938

Percentage of revenue (Non-GAAP)

25

%

33

%

12

%

24

%

19

%

Net income per diluted weighted-average common and common-equivalent share (GAAP)

$

0.39

$

0.49

$

0.46

$

1.00

$

1.16

Per share impact of non-GAAP adjustments identified above

(0.07

)

(0.02

)

(0.35

)

0.09

(0.36

)

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.32

$

0.47

$

0.11

$

1.09

$

0.80

Diluted weighted-average common and common-equivalent shares outstanding

178,590

177,138

175,500

176,592

175,269

Exhibit 3

COGNEX CORPORATION

Balance Sheets

(Unaudited)

Dollars in thousands

December 31, 2020

December 31, 2019

Assets

Cash and investments

$

767,438

$

845,353

Accounts receivable

125,696

103,447

Inventories

60,830

60,261

Property, plant, and equipment

79,173

89,443

Operating lease assets

22,582

17,522

Goodwill and intangible assets

259,633

282,935

Deferred tax assets

434,704

449,519

Other assets

50,646

37,455

Total assets

$

1,800,702

$

1,885,935

Liabilities and Shareholders' Equity

Accounts payable and accrued expenses

$

93,534

$

70,065

Deferred revenue and customer deposits

21,274

14,432

Operating lease liabilities

26,230

17,973

Income taxes

72,551

93,009

Deferred tax liabilities

314,952

332,344

Other liabilities

9,959

2,402

Shareholders' equity

1,262,202

1,355,710

Total liabilities and shareholders' equity

$

1,800,702

$

1,885,935

Susan Conway

Investor Relations

+1 508-650-3353

[email protected]

Source: Cognex Corporation

Categories

Business Wire Press Releases

Next Articles